Kin KC, Hill D, Feldman SR (June 2016). "Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis". Expert Review of Clinical Pharmacology. 9 (6): 789–797. doi:10.1080/17512433.2016.1179574. PMID27089906. S2CID38261070.
Smith EL, Pincus SH, Donovan L, Holick MF (September 1988). "A novel approach for the evaluation and treatment of psoriasis. Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis". Journal of the American Academy of Dermatology. 19 (3): 516–528. doi:10.1016/S0190-9622(88)70207-8. PMID2459166.
Huckins D, Felson DT, Holick M (November 1990). "Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study". Arthritis and Rheumatism. 33 (11): 1723–1727. doi:10.1002/art.1780331117. PMID2242069.
Mazzaferro S, Goldsmith D, Larsson TE, Massy ZA, Cozzolino M (March 2014). "Vitamin D metabolites and/or analogs: which D for which patient?". Current Vascular Pharmacology. 12 (2): 339–349. doi:10.2174/15701611113119990024. PMID23713876.
Holick MF, Schnoes HK, DeLuca HF, Suda T, Cousins RJ (July 1971). "Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine". Biochemistry. 10 (14): 2799–2804. doi:10.1021/bi00790a023. PMID4326883.
Kircik L (August 2009). "Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis". Journal of Drugs in Dermatology. 8 (8 Suppl): s9-16. PMID19702031.
Kin KC, Hill D, Feldman SR (June 2016). "Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis". Expert Review of Clinical Pharmacology. 9 (6): 789–797. doi:10.1080/17512433.2016.1179574. PMID27089906. S2CID38261070.
Smith EL, Pincus SH, Donovan L, Holick MF (September 1988). "A novel approach for the evaluation and treatment of psoriasis. Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis". Journal of the American Academy of Dermatology. 19 (3): 516–528. doi:10.1016/S0190-9622(88)70207-8. PMID2459166.
Huckins D, Felson DT, Holick M (November 1990). "Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study". Arthritis and Rheumatism. 33 (11): 1723–1727. doi:10.1002/art.1780331117. PMID2242069.
Mazzaferro S, Goldsmith D, Larsson TE, Massy ZA, Cozzolino M (March 2014). "Vitamin D metabolites and/or analogs: which D for which patient?". Current Vascular Pharmacology. 12 (2): 339–349. doi:10.2174/15701611113119990024. PMID23713876.
Holick MF, Schnoes HK, DeLuca HF, Suda T, Cousins RJ (July 1971). "Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine". Biochemistry. 10 (14): 2799–2804. doi:10.1021/bi00790a023. PMID4326883.
Kin KC, Hill D, Feldman SR (June 2016). "Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis". Expert Review of Clinical Pharmacology. 9 (6): 789–797. doi:10.1080/17512433.2016.1179574. PMID27089906. S2CID38261070.